200 related articles for article (PubMed ID: 32889753)
1. Transforming growth factor β-mediated micromechanics modulates disease progression in primary myelofibrosis.
Teodorescu P; Pasca S; Jurj A; Gafencu G; Joelsson JP; Selicean S; Moldovan C; Munteanu R; Onaciu A; Tigu AB; Buse M; Zimta AA; Stiufiuc R; Petrushev B; Desmirean M; Dima D; Vlad C; Bergthorsson JT; Berce C; Ciurea S; Ghiaur G; Tomuleasa C
J Cell Mol Med; 2020 Oct; 24(19):11100-11110. PubMed ID: 32889753
[TBL] [Abstract][Full Text] [Related]
2. Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines.
Bock O; Höftmann J; Theophile K; Hussein K; Wiese B; Schlué J; Kreipe H
Am J Pathol; 2008 Apr; 172(4):951-60. PubMed ID: 18349123
[TBL] [Abstract][Full Text] [Related]
3. P-Selectin Sustains Extramedullary Hematopoiesis in the Gata1 low Model of Myelofibrosis.
Spangrude GJ; Lewandowski D; Martelli F; Marra M; Zingariello M; Sancillo L; Rana RA; Migliaccio AR
Stem Cells; 2016 Jan; 34(1):67-82. PubMed ID: 26439305
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor β- and interleukin 13-producing mast cells are associated with fibrosis in bone marrow.
Nakayama S; Yokote T; Hiraoka N; Akioka T; Nishiwaki U; Miyoshi T; Iwaki K; Fumimoto A; Masuda Y; Hatooka J; Fujimoto M; Nishimura Y; Tsuji M
Hum Pathol; 2017 Apr; 62():180-186. PubMed ID: 28159675
[TBL] [Abstract][Full Text] [Related]
5. Neoplastic fibrocytes play an essential role in bone marrow fibrosis in Jak2V617F-induced primary myelofibrosis mice.
Ozono Y; Shide K; Kameda T; Kamiunten A; Tahira Y; Sekine M; Akizuki K; Nakamura K; Iwakiri H; Sueta M; Hidaka T; Kubuki Y; Yamamoto S; Hasuike S; Sawaguchi A; Nagata K; Shimoda K
Leukemia; 2021 Feb; 35(2):454-467. PubMed ID: 32472085
[TBL] [Abstract][Full Text] [Related]
6. Identification of new target molecules PTK2, TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis.
Bock O; Muth M; Theophile K; Winter M; Hussein K; Büsche G; Kröger N; Kreipe H
Br J Haematol; 2009 Sep; 146(5):510-20. PubMed ID: 19604240
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow fibrosis in primary myelofibrosis: pathogenic mechanisms and the role of TGF-β.
Agarwal A; Morrone K; Bartenstein M; Zhao ZJ; Verma A; Goel S
Stem Cell Investig; 2016; 3():5. PubMed ID: 27358897
[TBL] [Abstract][Full Text] [Related]
8. The production of transforming growth factor-beta in acute megakaryoblastic leukemia and its possible implications in myelofibrosis.
Terui T; Niitsu Y; Mahara K; Fujisaki Y; Urushizaki Y; Mogi Y; Kohgo Y; Watanabe N; Ogura M; Saito H
Blood; 1990 Apr; 75(7):1540-8. PubMed ID: 2317561
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression of transforming growth factor beta-1 (TGF beta-1) per se does not discriminate fibrotic from non-fibrotic chronic myeloproliferative disorders.
Bock O; Loch G; Schade U; von Wasielewski R; Schlué J; Kreipe H
J Pathol; 2005 Apr; 205(5):548-57. PubMed ID: 15726648
[TBL] [Abstract][Full Text] [Related]
10. TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche.
Yao JC; Oetjen KA; Wang T; Xu H; Abou-Ezzi G; Krambs JR; Uttarwar S; Duncavage EJ; Link DC
J Clin Invest; 2022 Jun; 132(11):. PubMed ID: 35439167
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow immunohistochemical studies of angiogenic cytokines and their receptors in myelofibrosis with myeloid metaplasia.
Chou JM; Li CY; Tefferi A
Leuk Res; 2003 Jun; 27(6):499-504. PubMed ID: 12648509
[TBL] [Abstract][Full Text] [Related]
12. Systemic transforming growth factor-beta in patients with bone marrow fibrosis--pathophysiological implications.
Rameshwar P; Chang VT; Thacker UF; Gascón P
Am J Hematol; 1998 Oct; 59(2):133-42. PubMed ID: 9766798
[TBL] [Abstract][Full Text] [Related]
13. Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis.
Le Bousse-Kerdilès MC; Martyré MC
Ann Hematol; 1999 Oct; 78(10):437-44. PubMed ID: 10550553
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast dynamics as an in vitro screening platform for anti-fibrotic drugs in primary myelofibrosis.
Tomuleasa C; Selicean S; Gafencu G; Petrushev B; Pop L; Berce C; Jurj A; Trifa A; Rosu AM; Pasca S; Magdo L; Zdrenghea M; Dima D; Tanase A; Frinc I; Bojan A; Berindan-Neagoe I; Ghiaur G; Ciurea SO
J Cell Physiol; 2018 Jan; 233(1):422-433. PubMed ID: 28294327
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis.
Le Bousse-Kerdilès MC; Martyré MC;
Pathol Biol (Paris); 2001 Mar; 49(2):153-7. PubMed ID: 11317961
[TBL] [Abstract][Full Text] [Related]
16. Activation of non-canonical TGF-β1 signaling indicates an autoimmune mechanism for bone marrow fibrosis in primary myelofibrosis.
Ciaffoni F; Cassella E; Varricchio L; Massa M; Barosi G; Migliaccio AR
Blood Cells Mol Dis; 2015 Mar; 54(3):234-41. PubMed ID: 25703685
[TBL] [Abstract][Full Text] [Related]
17. Cellular distribution of platelet-derived growth factor, transforming growth factor-beta, basic fibroblast growth factor, and their receptors in normal bone marrow.
Yoon SY; Tefferi A; Li CY
Acta Haematol; 2000; 104(4):151-7. PubMed ID: 11279303
[TBL] [Abstract][Full Text] [Related]
18. Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis.
Schmitt A; Jouault H; Guichard J; Wendling F; Drouin A; Cramer EM
Blood; 2000 Aug; 96(4):1342-7. PubMed ID: 10942376
[TBL] [Abstract][Full Text] [Related]
19. Role of TGF-β1/miR-382-5p/SOD2 axis in the induction of oxidative stress in CD34+ cells from primary myelofibrosis.
Rossi C; Zini R; Rontauroli S; Ruberti S; Prudente Z; Barbieri G; Bianchi E; Salati S; Genovese E; Bartalucci N; Guglielmelli P; Tagliafico E; Rosti V; Barosi G; Vannucchi AM; Manfredini R;
Mol Oncol; 2018 Dec; 12(12):2102-2123. PubMed ID: 30259659
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia.
Le Bousse-Kerdilès MC; Chevillard S; Charpentier A; Romquin N; Clay D; Smadja-Joffe F; Praloran V; Dupriez B; Demory JL; Jasmin C; Martyré MC
Blood; 1996 Dec; 88(12):4534-46. PubMed ID: 8977245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
